Last reviewed · How we verify

Penthrox Inhaler — Competitive Intelligence Brief

Penthrox Inhaler (Penthrox Inhaler) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Volatile inhaled analgesic. Area: Pain Management / Emergency Medicine.

marketed Volatile inhaled analgesic Pain Management / Emergency Medicine Small molecule Live · refreshed every 30 min

Target snapshot

Penthrox Inhaler (Penthrox Inhaler) — Singapore General Hospital. Penthrox (methoxyflurane) is a volatile inhaled analgesic that provides rapid pain relief through central nervous system depression.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Penthrox Inhaler TARGET Penthrox Inhaler Singapore General Hospital marketed Volatile inhaled analgesic

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Volatile inhaled analgesic class)

  1. Singapore General Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Penthrox Inhaler — Competitive Intelligence Brief. https://druglandscape.com/ci/penthrox-inhaler. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: